Can I Take Calcium with Avodart (Dutasteride)?

Dutasteride (brand name Avodart) is a synthetic 5-alpha reductase inhibitor. It is FDA-approved for benign prostatic hyperplasia (BPH) and used off-label for androgenetic alopecia (male pattern hair loss). There is no known pharmacokinetic interaction between calcium and dutasteride: calcium does not chelate dutasteride in the gut, and it does not induce or inhibit the CYP3A4/CYP3A5 liver enzymes that metabolize the drug. Calcium and dutasteride can be taken together without a required separation window. The mechanisms that make calcium a timing problem for other medications, such as levothyroxine or bisphosphonates, simply do not apply to dutasteride's chemistry.

Why Dutasteride Isn't Chelation-Sensitive

Calcium interferes with some drugs by forming an insoluble complex with the drug molecule in the intestine, a process called chelation. This is why patients on levothyroxine or certain antibiotics are told to separate doses from calcium-containing products.

Dutasteride is a highly lipophilic azasteroid. It lacks the carboxylate, phosphate, or tetracycline-like functional groups that calcium ions bind. According to the FDA-approved prescribing information for Avodart, dutasteride absorption is governed by lipid solubility rather than ionic interactions, and the label does not list calcium among clinically significant interacting substances.

What actually changes dutasteride levels

Dutasteride is metabolized primarily through hepatic CYP3A4 and CYP3A5. Strong CYP3A4 inhibitors (for example, ketoconazole, ritonavir) can raise dutasteride blood levels, and inducers (for example, rifampicin, St. John's Wort) can lower them, based on the pharmacology described in the FDA label. Calcium, from food or a supplement, has no established effect on CYP3A4 or CYP3A5 activity at physiological intake levels.

What the evidence actually supports

No dedicated trial has tested concurrent calcium supplementation in men on dutasteride, because the interaction has no plausible mechanism to justify funding such a study. The large dutasteride outcome trials for BPH and prostate cancer risk reduction did not exclude calcium supplementation or flag it as a confounding variable, but this absence-of-signal is indirect evidence, not a study specifically designed to test the question. Readers should treat the "no interaction" conclusion as resting on mechanism (no chelation groups, no CYP3A4/3A5 effect) plus an absence of any reported signal in large trial populations, rather than on a dedicated interaction study. If your prescriber or pharmacist wants a primary citation for this reasoning, the FDA-approved Avodart label is the correct starting document to review together.

Evidence-status interaction assessment

Calcium's real interactions in a man taking dutasteride

The clinically important question for most men on Avodart is not whether calcium affects dutasteride, but whether calcium affects the other drugs commonly prescribed alongside it, since BPH and hair-loss patients are frequently older adults on multiple medications.

• Alpha-blockers (tamsulosin, silodosin): Not chelation-sensitive. No calcium separation is needed.
• Levothyroxine: Calcium carbonate is well documented to reduce levothyroxine absorption when taken together. The generally accepted practice, reflected in endocrine literature, is to take levothyroxine on an empty stomach and separate it from calcium by several hours. If you take both, ask your prescriber or pharmacist for the specific timing they want you to follow rather than relying on a single number here.
• Fluoroquinolone antibiotics (ciprofloxacin, levofloxacin): These are chelated by divalent cations including calcium, magnesium, and iron. Standard practice is to separate the antibiotic from calcium-containing products by roughly 2 hours before or several hours after, per the antibiotic's own labeling.
• Bisphosphonates (alendronate, risedronate): These require being taken on an empty stomach with plain water, well before any food, drink, or supplement including calcium, because simultaneous calcium substantially reduces bisphosphonate absorption. Follow the specific instructions on the bisphosphonate's label.

Calcium timing framework for men on dutasteride

Calcium safety questions independent of dutasteride

These matter for the same patient population, but they are calcium-and-age questions, not calcium-and-dutasteride questions.

Total daily intake and the upper limit

The NIH Office of Dietary Supplements sets the Tolerable Upper Intake Level for calcium at 2,000 mg/day for adults 51 and older (ODS calcium fact sheet). A typical diet already supplies a substantial share of that total, so adding a supplement without accounting for dietary intake can push some men above the limit. This is worth reviewing with your clinician regardless of dutasteride use.

The cardiovascular question is unsettled

Some meta-analyses have raised a possible association between supplemental calcium (without co-administered vitamin D) and cardiovascular events, while other reviews have not confirmed this. Major guideline bodies have stated that current evidence is insufficient to recommend for or against calcium and vitamin D supplementation for primary prevention of cardiovascular disease or cancer in community-dwelling adults. Because BPH patients are typically older men with baseline cardiovascular risk, this unsettled evidence is a reasonable topic to raise with a prescriber before adding high-dose supplemental calcium, independent of dutasteride.

Calcium intake and prostate cancer risk: not settled

Some observational studies have suggested a possible association between very high calcium intake and prostate cancer risk, with confounding by dairy fat intake acknowledged as a limitation. This association is not established as causal, and the specific numeric estimates from any one study should not be treated as a firm threshold without checking the primary paper. Because dutasteride is used in prostate-related indications, this is a reasonable discussion topic with a urologist, framed as an open question rather than a settled risk.

Choosing a calcium supplement form

Calcium carbonate requires stomach acid for dissolution, while calcium citrate does not depend on acid to the same degree. Men taking a proton pump inhibitor (such as omeprazole) may absorb calcium carbonate less reliably in a low-acid stomach environment; calcium citrate is generally considered the more reliable choice in that situation, though this should be confirmed with a pharmacist based on your specific PPI dose and duration.

Elemental calcium content differs by form: calcium carbonate is roughly 40% elemental calcium, while calcium citrate is roughly 21%. Check the "elemental calcium" line on the supplement facts panel rather than the total tablet weight, since confusing the two leads to unintentional under- or over-dosing.

Vitamin D3 supports intestinal calcium absorption and is commonly co-formulated with calcium supplements for bone health. Dutasteride has no known interaction with vitamin D.

Monitoring that matters on dutasteride

• PSA: Dutasteride typically lowers serum PSA meaningfully within the first several months of therapy. The FDA label instructs establishing a new PSA baseline after 3 to 6 months of treatment, and any confirmed rise from that new baseline warrants evaluation even if the absolute value looks normal. Calcium supplementation does not affect PSA assay results and does not interfere with this monitoring plan.
• Bone health: Dutasteride does not suppress testosterone to hypogonadal levels the way androgen deprivation therapy does, so it is not itself a driver of bone loss. Bone density screening decisions should be based on age and standard osteoporosis risk factors, not on dutasteride use.
• Serum calcium and kidney function: Men taking supplemental calcium at meaningful daily doses should have periodic serum calcium and kidney function checks, particularly if there is a history of kidney stones, hyperparathyroidism, or reduced kidney function. This applies whether or not the person is also on dutasteride.

Special populations

Chronic kidney disease. Calcium and phosphate metabolism are disrupted in CKD, and calcium supplementation in this setting should be managed by a nephrologist. Dutasteride itself does not require dose adjustment for renal impairment based on the FDA label, but calcium decisions are considerably more complex in CKD regardless.

History of kidney stones. Most kidney stones are calcium oxalate. Dietary calcium taken with meals can actually reduce oxalate absorption and may be protective; calcium taken separately from meals does not have this effect and may increase stone risk in susceptible individuals. This is a supplement-timing question that applies whether or not someone is on dutasteride.

Men on androgen deprivation therapy (ADT) for prostate cancer. ADT (leuprolide, degarelix, and similar agents) causes genuine hypogonadism and bone loss, and guideline bodies recommend calcium and vitamin D supplementation specifically in that context. Dutasteride is a different drug with a different mechanism; it does not lower testosterone to hypogonadal levels, and calcium/vitamin D guidance written for ADT patients should not be assumed to apply automatically to men taking dutasteride alone. If you are on both dutasteride and ADT, or considering ADT, this needs a direct conversation with your oncologist or urologist.

What to bring to your next appointment

• A complete list of every supplement, with brand name, elemental dose, and time of day taken
• Your total daily elemental calcium from diet plus supplements combined
• Any other chelation-sensitive medications you take (thyroid hormone, certain antibiotics, bisphosphonates) so timing can be set correctly for those drugs specifically
• Whether bone density screening is appropriate given your age and risk factors, independent of dutasteride
• Your cardiovascular risk profile if you are considering a calcium supplement above typical dietary levels

Men taking dutasteride for hair loss rather than BPH follow the same guidance on calcium, since the drug's absorption and metabolism do not differ by indication.

When to seek care sooner

Contact your prescriber promptly if you notice new urinary retention, blood in the urine, breast tenderness or enlargement, or a PSA rise from your new dutasteride baseline. Symptoms of hypercalcemia, such as persistent nausea, confusion, excessive thirst, or muscle weakness, in someone taking high-dose calcium supplements also warrant prompt medical evaluation rather than waiting for a routine visit.

Evidence boundary

Established: calcium has no chelation mechanism against dutasteride and no known effect on the CYP3A4/CYP3A5 pathways that metabolize it; no dose separation is required between the two. Plausible but not directly tested: reassurance from large dutasteride trial populations that did not restrict calcium use, which is supportive but not a dedicated interaction study. Not established: any precise numeric change in dutasteride levels, efficacy, or specific calcium-cardiovascular or calcium-prostate cancer risk figures; these require checking the primary literature directly with your prescriber or pharmacist rather than relying on any single summary, including this page.

This article is for general education and does not replace individualized medical advice. Bring your full medication and supplement list to your prescriber or pharmacist, and seek urgent care for new urinary retention, significant blood in the urine, or symptoms suggestive of hypercalcemia.